The effect of antihypertensive therapy on dry eye disease

References

• Gaffney EA, Tiffany JM, Yokoi N, Bron AJ. A mass and solute balance model for tear volume and osmolarity in the normal and the dry eye. Prog Retin Eye Res 2010;29:59–78
   PubMed Web of Science ®Google Scholar
• Iskeleli G, Karakoc Y, Abdula A. Tear film osmolarity in patients with thyroid ophthalmopathy. Jpn J Ophthalmol 2008;52:323–326
   PubMed Web of Science ®Google Scholar
• Srinivasan S, Joyce E, Jones LW. Tear osmolality and ferning patterns in postmenopausal women. Optom Vis Sci 2007;84:588–592
   PubMed Web of Science ®Google Scholar
• Farris RL, Stuchell RN, Mandel ID. Tear osmolarity variation in the dry eye. Trans Am Ophthalmol Soc 1986;84:250–268
   PubMedGoogle Scholar
• Blomquist PH. Ocular complications of systemic medication. Am J Med Sci 2011;342:62–69
   PubMed Web of Science ®Google Scholar
• Smidt D, Torpet LA, Nauntofte B, et al. Associations between oral and ocular dryness, labial and whole salivary flow rates, systemic diseases and medications in a sample of older people. Community Dent Oral Epidemiol 2011;39:276–288
   PubMed Web of Science ®Google Scholar
• Moss SE, Klein R, Klein BE. Long-term incidence of dry eye in an older population. Optom Vis Sci 2008;85:668–674
   PubMed Web of Science ®Google Scholar
• Rohrschneider K, Koch HR. Effects of acetazolamide (Diamox, Glaupax) on tear production. Oftalmologia 2003;59:28–31
   PubMedGoogle Scholar
• Moss SE, Klein R, Klein BE. Incidence of dry eye in an older population. Arch Ophthalmol 2004;122:369–373
   PubMed Web of Science ®Google Scholar
• Bergmann MT, Newman BL, Johnson NC Jr. The effect of a diuretic (hydrochlorothiazide) on tear production in humans. Am J Ophthalmol 1985;99:473–475
   PubMed Web of Science ®Google Scholar
• Schein OD, Hochberg MC, Munoz B, et al. Dry eye and dry mouth in the elderly: a population-based assessment. Arch Intern Med 1999;159:1359–1363
   PubMed Web of Science ®Google Scholar
• Irkec M, Bozkurt B, Sekeroglu MA, Orhan M. The reliability and validity inquiry of the Turkish interpretation of OSDI. 40th National Congress of Ophtalmology, Antalya, Oral presentation, Congress Abstract Book 2006; 93
   Google Scholar
• Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the ocular surface disease index. Arch Ophthalmol 2000;118:615–621
   PubMed Web of Science ®Google Scholar
• Miller KL, Walt JG, Mink DR, et al. Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol 2010;128:94–101
   PubMed Web of Science ®Google Scholar
• Murube J. Tear osmolarity. Ocul Surf 2006;1:62–73
   Google Scholar
• Lemp MA, Bron AJ, Baudouin C, et al. Foulks GN, #Pepose |JS, Sullivan BD Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol 2011;151:792–798
   PubMed Web of Science ®Google Scholar
• Lucca JA, Nunez JN, Farris RL. A comparison of diagnostic tests for keratoconjunctivitis sicca: lactoplate, Schirmer, tear osmolarity. CLAO J 1990;16:109–112
   PubMedGoogle Scholar
• Farris RL. Tear osmolarity a new gold standard? Adv Exp Med Biol 1994;350:495–503
   PubMedGoogle Scholar
• Versura P, Profazio V, Campos EC. Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases. Curr Eye Res. 2010;35:553–564
   PubMed Web of Science ®Google Scholar
• Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye Workshop (2007). Ocul Surf 2007;5:108–152
   PubMed Web of Science ®Google Scholar
• Bron AJ. The Doyne Lecture. Reflections on the tears. Eye 1997;11:583–602
   PubMed Web of Science ®Google Scholar
• Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelines for the management of arteriel hypertension: 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Society of Cardiology. J Hypertens 2007;25:1105–1187
   PubMed Web of Science ®Google Scholar
• Moss SE, Klein R, Sjølie AK, et al. DIRECT Programme Study Group. Angiotensin receptor blockade not related to history of dry eye symptoms and treatment in The Diabetic Retinopathy Candesartan Trials (DIRECT). Acta Ophthalmol 2011;89:535–536
   Google Scholar
• Peeters AC, Netea MG, Kullberg BJ, et al. The effect of renin-angiotensin system inhibitors on pro- and antiinflammatory cytokine production. Immunology 1998;94:376–379
   PubMed Web of Science ®Google Scholar
• Sheth T, Parker T, Block A, et al. Comparison of the effects of omapatrilat and lisinopril on circulating neurohormones and cytokines in patients with chronic heart failure. Am J Cardiol 2002;90:496–500
   PubMed Web of Science ®Google Scholar